NewsRoom Articles - Page 107 of 596

ThursdayJun 01, 2023 4:20 am

420 with CNW — US Leaders Draw Attention to Cannabis Banking Bill Provision

A provision in the SAFE Banking measure has drawn criticism from several leaders and groups, including Democratic Senator Jack Reed, conservative advocacy associations and senior federal officials. The parties argue that the provision may unintentionally restrict the capacity of regulators to take action against those abusing financial services. Reed first raised his concerns about Section 10 of the SAFE Banking Act this month in a session held by the Senate Banking Committee to discuss the bill. The senator stated that the provision’s wording will make it more challenging for federal authorities to issue a warning regarding any customer relationships that…

WednesdayMay 31, 2023 4:20 pm

420 with CNW — Nevada Moves to Ease Cannabis Regulations for Police Recruits

More than 20 states now allow their residents to purchase recreational cannabis while dozens of states have launched medical marijuana markets. This has significantly expanded access to cannabis among the populace and allowed millions of Americans to purchase and consume marijuana legally. But since federal law still considers cannabis a Schedule I controlled substance, certain individuals can face serious consequences for consuming state-legal cannabis. For instance, people employed by the federal government or in safety-sensitive positions can lose their jobs for failing cannabis tests. In Nevada, authorities are proposing amendments to the state’s employment policy that would make it impossible…

WednesdayMay 31, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Finalizes DehydraTECH(TM)-CBD Batch Manufacturing for IND Filing This Summer and FDA Phase 1b Trial Commencement in October 2023

Lexaria just announced the completion of batch manufacturing of its patented DehydraTECH(TM)-processed CBD and placebo materials for its FDA Phase 1b HYPER-H23-1 human clinical study This is in line with the company’s IND filing with the FDA, which it looks to complete this summer, with potential authorization within 60 days FDA authorization will mark the commencement of Phase 1b trial patient dosing, with the study evaluating the safety and tolerability of DehydraTECH-CBD in hypertensive patients Filling into capsules of the manufactured DehydraTECH-CBD is expected to be completed before the end of this month, after which analytical release and stability testing…

WednesdayMay 31, 2023 4:20 am

420 with CNW — Google Unveils AI to Expedite Drug-Development Processes

Artificial intelligence (AI) now has the potential to significantly speed up the laborious, time-consuming, and currently low-success rate process of finding and approving new pharmaceuticals. Google Cloud introduced two new AI-powered tools — Multiomics and Target and Lead Identification Suites — on May 15, 2023, in an effort to aid pharmaceutical and biotech companies in accelerating the discovery of novel treatments and advancing medicine. According to a study published in the March 2021 issue of the “British Journal of Pharmacology,” the process of producing a new treatment currently takes between 12 and 15 years from the first idea to the…

TuesdayMay 30, 2023 4:20 pm

420 with CNW — The DEA Wants Delta-8 Banned, CBD Severely Restricted

While delta-9 tetrahydrocannabinol (THC) and cannabidiol (CBD) are the most publicly known cannabinoids, cannabis produces more than 100 different cannabinoids. Delta-9 THC is the main psychoactive agent in cannabis, and it is illegal at the federal level and in states that do not allow recreational or medical cannabis sales. In recent years, players in the cannabis industry have turned to another psychoactive cannabinoid called delta-8 THC. The result has been an influx of delta-8 THC products even though the FDA has not evaluated or approved such products as safe for public consumption. The labeling on these products often contains misleading…

TuesdayMay 30, 2023 4:20 am

420 with CNW — Analysis Finds Significant Number of US Employees Failing Cannabis Drug Tests

A study by testing company and medical lab Quest Diagnostics has revealed that Americans are failing marijuana tests in unprecedented numbers. The firm’s annual analysis found that the number of U.S. employees who tested positive for marijuana was the highest Quest Diagnostics had seen since it started collecting data on workplace drug testing in 1988. After analyzing more than 6 million urine tests for traces of marijuana in 2022, the firm found that 4.3% were positive for cannabis compared to 3.9% in 2021. Quest Diagnostics tested urine samples from general employees. This group excludes safety-sensitive and federally mandated employees, such…

FridayMay 26, 2023 4:20 pm

420 with CNW — As Security Concerns Escalate, B.C. Alters Law on Cannabis Shop Window Coverings

Last Friday night, all across Vancouver, British Columbia, cannabis retail shops were taking the coverings off of their windows. This was after the government altered the law in response to a spike in cannabis store robberies in the province. The move is meant to protect both customers and sellers. Until recently, the opaque film window coverings were a condition of cannabis retail shop provincial licensing, ensuring that none of the goods were visible from the outside; the approach was an attempt to keep minors away from cannabis products. While some stores have roomy interiors or stylish furnishings that deftly cover…

FridayMay 26, 2023 10:30 am

The Green Label Expo: Las Vegas 2023 Edition

The Green Label Expo 2023 edition will be held at the World Market Center in Las Vegas on the 13th & 14th of September, welcoming thousands of CBD experts, alternative product professionals, counterculture experts, and business owners to discover a vast array of global suppliers in trending sectors such as beauty, health & wellness, pet products, foods, business services, and more. As the need for embracing alternative products surges, the vibrant city of Las Vegas is set to welcome the largest trade show for CBD and alternative product professionals. This two-day event will feature an extensive showcase of innovative products/services,…

FridayMay 26, 2023 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Shareholders Approve Board Appointments Amid Push for Diversity; Vote to Endorse 6 Agenda Items in 2023 Annual Shareholder Meeting

Lexaria held its virtual 2023 Annual Shareholders meeting on May 9, 2023 On the agenda were the election of six director nominees, the ratification of the appointment of the company’s independent registered public accounting firm, and the approval of a one-time repricing of specific issued stock options, among others All items presented received approval, with the highest approval percentage standing at 97.6% and the lowest at 63.1% The meeting presented an opportunity for Lexaria to evaluate areas of expertise that would provide additional benefits to the company and its shareholders while also adding diversity to its board Lexaria Bioscience (NASDAQ:…

FridayMay 26, 2023 4:20 am

420 with CNW — NIDA Director Wants Cannabis Products Federally Regulated

According to a senior federal health official, cannabis products must be controlled as states continue to legalize marijuana. Nora Volkow, director of NIDA, stated that while it would be ideal if states took their time enacting reform, the reality is that they are enacting reform and people need to know what they can do to lessen negative impacts. Volkow asserted that it is crucial to regulate the sale of products and inform the public about potential negative consequences. The official's remarks are noteworthy because, although she did not specifically demand federal reform, such a shift in policy would be required…